Literature DB >> 20035896

Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies.

Roy van der Meel1, William M Gallagher, Sabrina Oliveira, Aisling E O'Connor, Raymond M Schiffelers, Annette T Byrne.   

Abstract

Molecular imaging is the visualization, characterization and measurement of biological processes at the molecular and cellular level. In oncology, molecular imaging approaches can be directly applied as translational biomarkers of disease progression. In this article, selected imaging modalities are discussed with respect to this role. Recent studies focusing on emerging imaging biomarkers and new developments in the field are highlighted. Importantly, because ex vivo or tissue-based imaging now represents an important tool in the discovery and validation of oncology biomarkers, special attention is given to this resurgent field. Copyright (c) 2009 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 20035896     DOI: 10.1016/j.drudis.2009.12.003

Source DB:  PubMed          Journal:  Drug Discov Today        ISSN: 1359-6446            Impact factor:   7.851


  18 in total

1.  Novel positron emission tomography tracer distinguishes normal from cancerous cells.

Authors:  Muhammad Saeed; David Sheff; Amnon Kohen
Journal:  J Biol Chem       Date:  2011-08-08       Impact factor: 5.157

2.  Has discovery-based cancer research been a bust?

Authors:  R J Epstein
Journal:  Clin Transl Oncol       Date:  2013-09-04       Impact factor: 3.405

3.  Targeting the de novo biosynthesis of thymidylate for the development of a PET probe for pancreatic cancer imaging.

Authors:  Thushani D Nilaweera; Muhammad Saeed; Amnon Kohen
Journal:  Biochemistry       Date:  2015-01-27       Impact factor: 3.162

4.  99mTc-HYNIC-spermine for imaging polyamine transport system-positive tumours: preclinical evaluation.

Authors:  Sabrina Pesnel; Yves Guminski; Arnaud Pillon; Stéphanie Lerondel; Thierry Imbert; Nicolas Guilbaud; Anna Kruczynski; Christian Bailly; Alain Le Pape
Journal:  Eur J Nucl Med Mol Imaging       Date:  2011-06-10       Impact factor: 9.236

5.  Multimodal interventional molecular imaging of tumor margins and distant metastases by targeting αvβ3 integrin.

Authors:  Anton Bunschoten; Tessa Buckle; Nils L Visser; Joeri Kuil; Hushan Yuan; Lee Josephson; Alexander L Vahrmeijer; Fijs W B van Leeuwen
Journal:  Chembiochem       Date:  2012-04-13       Impact factor: 3.164

Review 6.  PET/SPECT molecular imaging in clinical neuroscience: recent advances in the investigation of CNS diseases.

Authors:  Feng-Mei Lu; Zhen Yuan
Journal:  Quant Imaging Med Surg       Date:  2015-06

7.  Heptamethine cyanine based (64)Cu-PET probe PC-1001 for cancer imaging: synthesis and in vivo evaluation.

Authors:  Li Xiao; Yi Zhang; Wei Yue; Xiuzhen Xie; Ji-Ping Wang; Mahendra D Chordia; Leland W K Chung; Dongfeng Pan
Journal:  Nucl Med Biol       Date:  2013-02-01       Impact factor: 2.408

Review 8.  Molecular and clinical implementations of ovarian cancer mouse avatar models.

Authors:  Amira A Zayed; Sumithra J Mandrekar; Paul Haluska
Journal:  Chin Clin Oncol       Date:  2015-09

9.  Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.

Authors:  Denarda Dangaj; Evripidis Lanitis; Aizhi Zhao; Shree Joshi; Yi Cheng; Raphael Sandaltzopoulos; Hyun-Jeong Ra; Gwenn Danet-Desnoyers; Daniel J Powell; Nathalie Scholler
Journal:  Cancer Res       Date:  2013-05-30       Impact factor: 12.701

Review 10.  Cholecystokinin-2 Receptor Targeting with Radiolabeled Peptides: Current Status and Future Directions.

Authors:  Maximilian Klingler; Anton Amadeus Hörmann; Elisabeth Von Guggenberg
Journal:  Curr Med Chem       Date:  2020       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.